Mark Kemp
Executive Director of Medicinal Chemistry @Centessa Pharmaceuticals
Signup · Get unlimited contacts
WORK HISTORY
Executive Director of Medicinal Chemistry @Centessa Pharmaceuticals
Cambridge, GB
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients. It is developing potential best-in-class orexin receptor 2 (OX2R) agonists intended to be orally administered for the treatment of sleep-wake disorders including narcolepsy type 1 (NT1), narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH), and excessive daytime sleepiness (EDS) in neurological, neurodegenerative, and psychiatric conditions.
EDUCATION
University of Southampton
BSc (first class) & PhD, Chemistry
SKILLS
ABOUT MARK KEMP
A highly experienced medicinal chemist with a strong track record of delivering clinical candidates and leading large research teams across a range of therapeutic areas. Inventor on >40 patent applications.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.